HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term experience with nadolol in treatment of hypertension and angina pectoris.

Abstract
Two-hundred ninety-one patients with hypertension and 313 patients with angina pectoris were enrolled and treated with nadolol for up to 2 years. The efficacy of nadolol in hypertension and angina was maintained over the 2-year period. Discontinuation because of an adverse reaction occurred with 8.3% of the hypertensive patients and 8.6% of the angina patients. The observed reactions were typical of those which occur with beta-blocking drugs. Serum creatinine levels fell significantly (p less than 0.05) after 12 months of treatment for both the angina and hypertensive patients. After 24 months of treatment the serum creatinine levels had decreased 20% from baseline (p less than 0.001). Blood urea nitrogen levels fell in the angina patients after 12 months of treatment but not in the hypertensive patients. Nadolol is safe and effective for the long-term treatment of both hypertension and angina. Renal function, as measured by serum creatinine levels, improved with long-term treatment.
AuthorsJ C Alexander, M H Christie, K A Vernam, R S Fand, W B Shafer
JournalAmerican heart journal (Am Heart J) Vol. 108 Issue 4 Pt 2 Pg. 1136-40 (Oct 1984) ISSN: 0002-8703 [Print] United States
PMID6148874 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Diuretics
  • Propanolamines
  • Nadolol
  • Creatinine
Topics
  • Adolescent
  • Adrenergic beta-Antagonists (adverse effects, therapeutic use)
  • Adult
  • Aged
  • Angina Pectoris (drug therapy)
  • Blood Pressure (drug effects)
  • Blood Urea Nitrogen
  • Clinical Trials as Topic
  • Creatinine (blood)
  • Diuretics (therapeutic use)
  • Dizziness (chemically induced)
  • Drug Therapy, Combination
  • Erectile Dysfunction (chemically induced)
  • Fatigue (chemically induced)
  • Female
  • Heart Rate (drug effects)
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Nadolol
  • Propanolamines (adverse effects, therapeutic use)
  • Respiratory Sounds
  • Sleep Stages
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: